This study shows Class I evidence that weekly subcutaneous etanercept is well tolerated in Alzheimer disease dementia.
No takes yet. Share an insight, caveat, or question.
Butchart et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: